A TRIAL OF OXYPHENCYCLIMINE, A NEW ANTICHOLINERGIC AGENT.
D035843:Biomedical Research; D018680:Cholinergic Antagonists; D004381:Duodenal Ulcer; D004415:Dyspepsia; D006548:Hernia, Diaphragmatic; D006801:Humans; D000077771:Methantheline; D010276:Parasympatholytics; D011178:Postgastrectomy Syndromes; D011743:Pyrimidines; D000644:Quaternary Ammonium Compounds; D011859:Radiography; D013276:Stomach Ulcer; D014116:Toxicology
D018680:Cholinergic Antagonists; D010276:Parasympatholytics; D011743:Pyrimidines; D000644:Quaternary Ammonium Compounds; D000077771:Methantheline; C100201:oxyphencyclimine
CLINICAL RESEARCH; DIAPHRAGMATIC HERNIA; DUODENAL ULCER; DYSPEPSIA; METHANTHELINE; PARASYMPATHOLYTICS; POSTGASTRECTOMY SYNDROMES; RADIOGRAPHY; STOMACH ULCER; TOXICOLOGIC REPORT